Key statistics
As of last trade, Biontech SE (22UA:DUS) traded at 90.75, 29.64% above the 52 week low of 70.00 set on Aug 05, 2024.
52-week range
Open | 90.65 |
---|---|
High | 95.40 |
Low | 90.65 |
Bid | 90.00 |
Offer | 90.60 |
Previous close | 92.05 |
Average volume | 9.03k |
---|---|
Shares outstanding | 239.74m |
Free float | 214.95m |
P/E (TTM) | -- |
Market cap | 28.20bn USD |
EPS (TTM) | -2.02 USD |
Data delayed at least 15 minutes, as of Mar 13 2025 18:31 BST.
More ▼
- BioNTech veröffentlicht Ergebnisse für das vierte Quartal und das Geschäftsjahr 2024 sowie Informationen zur Geschäftsentwicklung
- BioNTech Announces Fourth Quarter and Full Year 2024 Financial Results and Corporate Update
- BioNTech to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on March 10, 2025
- BioNTech veröffentlicht am 10. März 2025 Ergebnisse für das vierte Quartal und das Geschäftsjahr 2024 und informiert über operativen Fortschritt
- EQS-News: MIG Capital navigates a demanding market environment in 2024 and looks ahead to 2025 with cautious optimism
- EQS-News: MIG Capital and CoreMedic announce fresh funding in Series B Extension
- BioNTech Completes Acquisition of Biotheus
- BioNTech schließt Übernahme von Biotheus ab
- Original-Research: Medigene AG (von First Berlin Equity Research GmbH): Buy
- EQS-News: Healthcare Specialists GENUI and SHS Capital jointly invest in ROTOP, a leading manufacturer and CDMO of radiopharmaceuticals
More ▼